Lv5
802 积分 2024-10-21 加入
Antiplatelet therapy and central nervous system hematomas: a cohort study using real-world data from the FAERS and vigiaccess databases
7个月前
已完结
Ocular adverse events associated with platins: a disproportionality analysis of pharmacovigilance data and extensive systematic review of case reports
7个月前
已完结
Unveiling the hidden risk of caspofungin: insights from three adverse event reporting systems and network pharmacology integration
7个月前
已关闭
The primary site of head and neck squamous cell carcinoma predicts survival benefits of EGFR inhibitors: A systematic review and meta-analysis
7个月前
已完结
Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma
7个月前
已完结
Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma
7个月前
已完结
Analysis of Immune-Related Adverse Events of Pembrolizumab Using FAERS Database
7个月前
已完结
[Research progress on the mechanisms of resistance to cetuximab targeted therapy in head and neck squamous cell carcinoma]
7个月前
已完结
Emerging EGFR-Targeted Therapy in Head and Neck Cancer
7个月前
已完结
Applications and challenges of EGFR inhibitors in the treatment of nasopharyngeal carcinoma
7个月前
已完结
皖公网安备34019202002308
